Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	Study Results


	Related Studies

Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease

This study has been completed.

Study NCT01387178 Information provided by GlaxoSmithKline

First Received on June 16, 2011. Last Updated on November 23, 2011 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Additional conditions recognized in this trial

Chronic Disease
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiration Disorders

More general conditions related to this trial

Disease Attributes
Pathologic Processes
Respiratory Tract Diseases

Interventions listed in this trial

tiotropium bromide (TIO)

Additional drug interventions recognized in this trial

Fluticasone
Salmeterol
Tiotropium

Sponsors listed in this trial

GlaxoSmithKline

Back to top of Main Content